InsidersTradesSigma
Follow the 인투셀 stock price and the full insider trade history of the company, a listed issuer based in South Korea. Shares are quoted on the KR market, under the oversight of DART (FSS). Operating in the Health Care sector, 인투셀 has recorded 3 insider filings. Market capitalisation: €254.9bn. The latest transaction was filed on 5 June 2026 (Purchase). Among the most active insiders: 이향숙. Every trade is accessible without an account.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
인투셀 是一家在 XKRX 市场上市的医疗保健和制药公司。它专注于开发创新的疗法和健康解决方案。